Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Motion Sickness, Space, Motion Simulation, Parabolic Flight
Interventions: DPI-386 Nasal Gel, Other (e.g., promethazine, meclizine); Drug
Lead sponsor: Repurposed Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Breast Cancer
Interventions: Contrast Enhanced Digital Mammography; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 35 Years and older · Female only
Enrollment: 461 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Renal Cell Carcinoma
Interventions: OTL38, Intraoperative fluorescence imaging system; Drug · Device
Lead sponsor: Chandru Sundaram; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Melanoma, Head and Neck Cancer, Breast Cancer
Interventions: Sentinella Intraoperative imaging protocol; Device
Lead sponsor: Oncovision Inc; Industry
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Major Depressive Disorder
Interventions: Active Transcranial Magnetic Simulation, Sham Transcranial Magnetic Stimulation; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer Screening
Interventions: contrast enhanced digital mammography (CEDM), whole breast screening ultrasound (WBUS); Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 30 Years and older · Female only
Enrollment: 487 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Major Depressive Disorder (MDD), Suicidal Ideation, Hospitalization in Children
Interventions: Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation Sham; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 14 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Major Depressive Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation; Device
Lead sponsor: Neuronetics; Other
Eligibility: 18 Years to 70 Years
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 13
States / cities: Poway, California • Stanford, California • Chicago, Illinois + 9 more

Conditions: Episodic Memory, Healthy
Interventions: Transcranial magnetic stimulation; Other
Lead sponsor: Boston College; Other
Eligibility: 18 Years to 35 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Autism Spectrum Disorder
Interventions: Transcranial Magnetic Stimulation (TMS); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Traumatic Brain Injury (TBI)
Interventions: Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation, Magnetic resonance imaging (MRI); Device · Diagnostic Test
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Paroxysmal AF
Interventions: Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation System; Device
Lead sponsor: Medtronic Cardiac Ablation Solutions; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 24
States / cities: Jonesboro, Arkansas • La Jolla, California • Sacramento, California + 19 more

Conditions: Dystonia, Tremor
Interventions: repetitive Transcranial Magnetic Stimulation (rTMS), Control group; Device · Other
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Apathy, Stroke, Stroke Sequelae, Stroke/Brain Attack, Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic), Motivation, Abulia
Interventions: MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active), MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham), Brainsight Neuronavigation System; Device · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 40 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Depression
Interventions: Transcranial Magnetic Stimulation; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: White River Junction, Vermont

Conditions: Parkinson Disease, REM Sleep Behavior Disorder
Interventions: MRI; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Ann Arbor Stage I Childhood Hodgkin Lymphoma, Ann Arbor Stage II Childhood Hodgkin Lymphoma, Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma
Interventions: Conventional Surgery, Cyclophosphamide, Doxorubicin Hydrochloride, Prednisone, Radiation Therapy, Vincristine Sulfate; Procedure · Drug · Radiation
Lead sponsor: Children's Oncology Group; Network
Eligibility: 1 Month to 21 Years
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2026
U.S. locations: 147
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 113 more

Conditions: Leukoplakia, Periodontal Disease
Interventions: Ketorolac Rinse; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Isolated Cervical Dystonia
Interventions: Transcranial Magnetic Stimulation (TMS), Placebo, trihexyphenidyl 10mg; Device · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Frailty
Interventions: Magnetic Mitohormesis Therapy; Other
Lead sponsor: Auburn University; Other
Eligibility: 60 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Cancer, Health Promotion
Interventions: Interactive Preventive Health Record; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 3
States / cities: Albuquerque, New Mexico • Portland, Oregon • Richmond, Virginia

Conditions: Glaucoma
Interventions: Visual field assessment; Diagnostic Test
Lead sponsor: Gainesville Eye Associates; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Gainesville, Georgia

Conditions: Depression
Interventions: Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 70 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Non-Arteritic Anterior Ischemic Optic Neuropathy
Interventions: Vision Restoration Therapy (NOVAVISION); Device
Lead sponsor: Emory University; Other
Eligibility: 30 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

Screening CEDM in Intermediate and High-Risk Patient Populations

Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma

Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes

Beat the Blues in Pregnancy Study - Transcranial Magnetic Stimulation

Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder

Causal Role of Brain Networks in Episodic Memory

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Managing Mild Traumatic Brain Injury Related Headaches With Repetitive Transcranial Magnetic Stimulation

Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)

Repetitive Transcranial Magnetic Stimulation (rTMS) for Dystonia and Tremor

Accelerated rTMS vs. Sham for Stroke Apathy

Assessing an EEG Biomarker of Response to TMS for Major Depression

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease

Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease

Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR

Accelerating TMS for Cervical Dystonia

Pilot-testing the Effect of Magnetic Mitohormesis Therapy for Treating Frailty in Older Adults

Implementing Personal Health Records to Promote Evidence-Based Cancer Screening

Comparison of Visual Field Assessments Between Three Perimeters

EEG Synchronized TMS Trial for Depression

Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy